Iwasaki, M., Hoshian, F., Tsuji, T., Hirose, N., Matsumoto, T., Kitatani, N., . . . Yabe, D. (2012). Predicting efficacy of dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels. Blackwell Publishing Ltd.
Styl ChicagoIwasaki, Masahiro, et al. Predicting Efficacy of Dipeptidyl Peptidase‐4 Inhibitors in Patients With Type 2 Diabetes: Association of Glycated Hemoglobin Reduction With Serum Eicosapentaenoic Acid and Docosahexaenoic Acid Levels. Blackwell Publishing Ltd, 2012.
Citace podle MLAIwasaki, Masahiro, et al. Predicting Efficacy of Dipeptidyl Peptidase‐4 Inhibitors in Patients With Type 2 Diabetes: Association of Glycated Hemoglobin Reduction With Serum Eicosapentaenoic Acid and Docosahexaenoic Acid Levels. Blackwell Publishing Ltd, 2012.